Well criz is also a MET inhibitor, so it's not impossible that some of its efficacy springs from that. Solid tumors are notably more complicated than a disease like CML, and so you can't extrapolate from preclinical measures to clinical results with anywhere near the same degree of confidence.
News 
Market Data 
Discover 
